Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?

Journal of Pediatrics

Volumn 160, Issue 4, 2012, Pages

  Robertson, Nicola J ^a   Tan, Sidhartha ^b   Groenendaal, Floris ^c   Van Bel, Frank ^c   Juul, Sandra E ^d   Bennet, Laura ^e   Derrick, Matthew ^b   Back, Stephen A ^f   Chavez Valdez, Raul ^g   Northington, Frances ^g   Gunn, Alistair Jan ^e   Mallard, Carina ^h  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

7 NITROINDAZOLE; ACETYLCYSTEINE; ALLOPURINOL; ALPHA TOCOPHEROL; ASCORBIC ACID; DEHYDROASCORBIC ACID; ERYTHROPOIETIN; HJ 619; IMIDAZOLE; JI 8; MELATONIN; NITRIC OXIDE SYNTHASE INHIBITOR; TETRAHYDROBIOPTERIN; UNCLASSIFIED DRUG; XENON;

BIOMIMETICS; BRAIN DAMAGE; BRAIN DISEASE; CONTINUOUS INFUSION; DRUG ACTIVITY; DRUG EFFECT; DRUG MEGADOSE; FETUS DISTRESS; HUMAN; LOW DRUG DOSE; NEUROPROTECTION; NEUROTOXICITY; NEWBORN DISEASE; NONHUMAN; NOTE; OPTIMAL DRUG DOSE; PERINATAL PERIOD; PRENATAL PERIOD; PRIORITY JOURNAL;

EID: 84858337595     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2011.12.052     Document Type: Note

References (158)

1. J. Kurinczuk, M. White-Koning, and N. Badawi Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy Early Hum Dev 86 2010 329 338
2. N. Marlow, A. Rose, C. Rands, and E.S. Draper Neuropsychological and educational problems at school age associated with neonatal encephalopathy Arch Dis Child Fetal Neonatal Ed 90 2005 F380 F387
3. C.M. Robertson, N.N. Finer, and M.G. Grace School performance of survivors of neonatal encephalopathy associated with birth asphyxia at term J Pediatr 114 1989 753 760
4. A. Edwards, P. Brocklehurst, A. Gunn, H. Halliday, E. Juszczak, and M. Levene Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data BMJ 340 2010 C363
5. P. Gluckman, J. Wyatt, D. Azzopardi, R. Ballard, A. Edwards, and D. Ferriero Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial Lancet 365 2005 663 670
6. D. Kelen, and N.J. Robertson Experimental treatments for hypoxic ischaemic encephalopathy Early Hum Dev 86 2010 369 377
7. M. Cilio, and D. Ferriero Synergistic neuroprotective therapies with hypothermia Semin Fetal Neonatal Med 15 2010 293 298
8. M. Carroll, and O. Beek Protection against hippocampal CA1 cell loss by post-ischaemic hypothermia is dependent on delay of initiation and duration Metab Brain Dis 7 1992 45 50
9. A. Gunn, T. Gunn, M. Gunning, C. Williams, and P. Gluckman Neuroprotection with prolonged head cooling started before postischemic seizures in fetal sheep Pediatrics 102 1998 1098 1106
10. N. Badawi, J.J. Kurinczuk, J.M. Keogh, L.M. Alessandri, F. O'Sullivan, P.R. Burton, P.J. Pemberton, and F.J. Stanley Intrapartum risk factors for newborn encephalopathy: the Western Australian case-control study BMJ 317 1998 1554 1558
11. S.M.L. Lehnardt, P. Follett, F.E. Jensen, R. Ratan, P.A. Rosenberg, and J.J. Volpe Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway PNAS 100 2003 8514 8519
12. S. Eklind, C. Mallard, A.L. Leverin, E. Gilland, K. Blomgren, and I. Mattsby-Baltzer Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury Eur J Neurosci 13 2001 1101 1106
13. N. Badawi, J.J. Kurinczuk, J.M. Keogh, L.M. Alessandri, F. O'Sullivan, and P.R. Burton Antepartum risk factors for newborn encephalopathy: the Western Australian case-control study BMJ 317 1998 1549 1553
14. K.P. Williams, and F. Galerneau Comparison of intrapartum fetal heart rate tracings in patients with neonatal seizures vs. no seizures: what are the differences? J Perinat Med 32 2004 422 425
15. S. Kumar, and S. Paterson-Brown Obstetric aspects of hypoxic ischemic encephalopathy Early Hum Dev 86 2010 339 344
16. K.P. Williams, and F. Galerneau Intrapartum fetal heart rate patterns in the prediction of neonatal acidemia Am J Obstet Gynaecol 188 2003 820 823
17. J. Westgate, B. Wibbens, L. Bennet, G. Wassink, J. Parer, and A. Gunn The intrapartum deceleration in center stage: a physiologic approach to the interpretation of fetal heart rate changes in labor Am J Obstet Gynaecol 197 2007 236.e1 236.e11
18. S. Vijgen, M. Westerhuis, B. Opmeer, G. Visser, K. Moons, and M. Porath Cost-effectiveness of cardiotocography plus ST analysis of the fetal electrocardiogram compared with cardiotocography only Acta Obstet Gynecol Scand 90 2011 772 778
19. J.T. Madsen, P. Jansen, C. Hesslinger, M. Meyer, J. Zimmer, and J.B. Gramsbergen Tetrahydrobiopterin precursor sepiapterin provides protection against neurotoxicity of 1-methyl-4-phenylpyridinium in nigral slice cultures J Neurochem 85 2003 214 223
20. R.H. Fabian, J. Perez-Polo, and T.A. Kent Perivascular nitric oxide and superoxide in neonatal cerebral hypoxia-ischemia Am J Physiol Heart Circ Physiol 295 2010 h1809 h1814
21. J. Vásquez-Vivar, J. Whitsett, M. Derrick, X. Ji, L. Yu, and S. Tan Tetrahydrobiopterin in the prevention of hypertonia in hypoxic fetal brain Ann Neurol 66 2009 323 331
22. S. Kaufman, G. Kapatos, R. McInnes, J. Schulman, and W. Rizzo Use of tetrahydropterins in the treatment of hyperphenylalaninemia due to defective synthesis of tetrahydrobiopterin: evidence that peripherally administered tetrahydropterins enter the brain Pediatrics 70 1982 376 380
23. R. Frye, L. Huffman, and G.R. Elliott Tetrahydrobiopterin as a novel therapeutic intervention for autism Neurotherapeutics 7 2010 241 249
24. M. Giewska, G. Hnatyszyn, L. Sagan, L. Cyryłowski, C. Zekanowski, and M. Modrzejewska Maternal tetrahydrobiopterin deficiency: the course of two pregnancies and follow-up of two children in a mother with 6-pyruvoyl- tetrahydropterin synthase deficiency J Inherit Metab Dis 2009 10.1007/s10545-009-1073-4
25. F.K. Trefz, D. Scheible, and G. Frauendienst-Egger Long-term follow-up of patients with phenylketonuria receiving tetrahydrobiopterin treatment J Inherit Metab Dis 2010 10.1007/s10545-010-9058-x
26. W. Endres, A. Niederwieser, H. Curtius, M. Wang, B. Ohrt, and J. Schaub Atypical phenylketonuria due to biopterin deficiency. Early treatment with tetrahydrobiopterin and neurotransmitter precursors, trials of monotherapy Helv Paediatr Acta 37 1982 489 498
27. R. Koch, K. Moseley, and F. Guttler Tetrahydrobiopterin and maternal PKU Mol Genet Metab 86 2005 S139 S141
28. J. Fink, P. Ravin, C. Argoff, R. Levine, R. Brady, and M. Hallett Tetrahydrobiopterin administration in biopterin-deficient progressive dystonia with diurnal variation Neurology 39 1989 1393 1395
29. M. Segawa, Y. Nomura, and N. Nishiyama Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease) Ann Neurol 54 2003 S32 S45
30. A. Altun, and B. Ugur-Altun Melatonin: therapeutic and clinical utilization Int J Clin Pract 61 2007 835 845
31. J.A. Boutin, V. Audinot, G. Ferry, and P. Delagrange Molecular tools to study melatonin pathways and actions Trends Pharmacol Sci 26 2005 412 419
32. R. Hardeland Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance Endocrine 27 2005 119 130
33. F. Luchetti, B. Canonico, M. Betti, M. Arcangeletti, F. Pilolli, and M. Piroddi Melatonin signaling and cell protection function FASAB J 24 2010 3603 3624
34. Y. Okatani, K. Okamoto, K. Hayashi, A. Wakatsuki, S. Tamura, and Y. Sagara Maternal-fetal transfer of melatonin in pregnant women near term J Pineal Res 25 1998 129 134
35. S. Reppert, R. Chez, A. Anderson, and D. Klein Maternal-fetal transfer of melatonin in the non-human primate Pediatr Res 13 1979 788 791
36. D. Sadowsky, S. Yellon, M. Mitchell, and P. Nathanielsz Lack of effect of melatonin on myometrial electromyographic activity in the pregnant sheep at 138-142 days gestation (term = 147 days gestation) Endocronology 128 1991 1812 1818
37. P. Vitte, C. Harthe, P. Lestage, B. Claustrat, and P. Bobillier Plasma, cerebrospinal fluid, and brain distribution of 14C-melatonin in rat: a biochemical and autoradiographic study J Pineal Res 5 1988 437 453
38. G. Mistraletti, G. Sabbatini, M. Taverna, M.A. Figini, M. Umbrello, and P. Magni Pharmacokinetics of orally administered melatonin in critically ill patients J Pineal Res 48 2010 142 147
39. I. Husson, B. Mespls, P. Bac, J. Vamecq, P. Evrard, and P. Gressens Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge Ann Neurol 51 2002 82 92
40. G. Jahnke, M. Marr, C. Myers, R. Wilson, G. Travlos, and C. Price Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats Toxicol Sci 50 1999 271 279
41. N. Robertson, E. Powell, S. Faulkner, A. Bainbridge, M. Chandrasekaran, and M. Hristova Improved neuroprotection with melatonin-augmented hypothermia vs hypothermia alone in a perinatal asphysia model EPAS 2012
42. A.K. Welin, P. Svedin, R. Lapatto, B. Sultan, H. Hagberg, and P. Gressens Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion Pediatr Res 61 2007 153 158
43. J. Jan, and M. O'Donnell Use of melatonin in the treatment of paediatric sleep disorders J Pineal Res 21 1996 193 199
44. E. Gitto, M. Karbownik, R. Reiter, D. Tan, S. Cuzzocrea, and P. Chiurazzi Effects of melatonin treatment in septic newborns Pediatr Res 50 2001 756 760
45. R. Reiter, D. Tan, J. Mayo, R. Sainz, J. Leon, and Z. Czarnocki Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans Acta Biochim Pol 50 2003 1129 1146
46. S.L. Miller, E.B. Yan, M. Castillo-Meléndez, G. Jenkin, and D.W. Walker Melatonin provides neuroprotection in the late-gestation fetal sheep brain in response to umbilical cord occlusion Dev Neurosci 27 2005 200 210
47. L.C. Hutton, M. Abbass, H. Dickinson, Z. Ireland, and D.W. Walker Neuroprotective properties of melatonin in a model of birth asphyxia in the spiny mouse (Acomys cahirinus) Dev Neurosci 31 2009 437 451
48. F. Fulia, E. Gitto, S. Cuzzocrea, R. Reiter, L. Dugo, and P. Gitto Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin J Pineal Res 31 2005 343 349
49. M. Bouslama, J. Renaud, P. Olivier, R.H. Fontaine, B. Matrot, and P. Gressens Melatonin prevents learning disorders in brain-lesioned newborn mice Neuroscience 150 2007 712 719
50. C. Kaur, V. Sivakumar, and E. Ling Melatonin protects periventricular white matter from damage due to hypoxia J Pineal Res 48 2010 185 193
51. P. Olivier, R.H. Fontaine, G. Loron, J. Van Steenwinckel, V. Biran, and V. Massonneau Melatonin promotes oligodendroglial maturation of injured white matter in neonatal rats PLoS One 22 2009 e7128
52. X. Wang, P. Svedin, C. Nie, R. Lapatto, C. Zhu, and M. Gustavsson N-acetylcysteine reduces lipopolysaccharide-sensitized hypoxic-ischemic brain injury Ann Neurol 61 2007 263 271
53. J. Bolanos, A. Almeida, V. Stewart, S. Peuchen, J. Land, and J. Clark Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases J Neurochem 68 1997 2227 2240
54. J. Chen, Y. Tu, C. Moon, V. Matarazzo, A. Palmer, and G. Ronnett The localization of neuronal nitric oxide synthase may influence its role in neuronal precursor proliferation and synaptic maintenance Dev Biol 269 2004 165 182
55. J. Perlman Intervention strategies for neonatal hypoxic-ischemic cerebral injury Clin Ther 28 2006 1353 1365
56. S. Ashwal, B. Tone, H. Tian, D. Cole, B. Liwnicz, and W. Pearce Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion in the rat pup Pediatr Res 46 1999 390 400
57. J. Castillo, R. Rama, and A. Davalos Nitric oxide-related brain damage in acute ischemic stroke Stroke 31 2000 852 857
58. N. Parikh, C. Katsetos, Q. Ashraf, S. Haider, A. Legido, and M. Delivoria-Papadopoulos Hypoxia-induced caspase-3 activation and DNA fragmentation in cortical neurons of newborn piglets: role of nitric oxide Neurochem Res 28 2003 1351 1357
59. M. Willmot, C. Gibson, L. Gray, S. Murphy, and P. Bath Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review Free Radic Biol Med 39 2005 412 425
60. H. Ji, H. Li, P. Martasek, L. Roman, T. Poulos, and R. Silverman Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping J Med Chem 52 2009 779 797
61. H. Ji, B. Stanton, J. Igarashi, H. Li, P. Martasek, and L. Roman Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors J Am Chem Soc 130 2008 3900 3914
62. H. Ji, S. Tan, J. Igarashi, H. Li, M. Derrick, and P. Martasek Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy Ann Neurol 65 2009 209 217
63. L. Yu, M. Derrick, H. Ji, R. Silverman, J. Whitsett, and J. Vasquez-Vivar Neuronal NOS inhibition prevents cerebral palsy following hypoxia-ischemia in fetal rabbits: Comparison between JI-8 and 7-nitroindazole Dev Neurosci 33 2011 312 319
64. E.R. van den Tweel, C. Peeters-Scholte, F. van Bel, C.J. Heijnen, and F. Groenendaal Inhibition of nNOS and iNOS following hypoxia-ischaemia improves long-term outcome but does not influence the inflammatory response in the neonatal rat brain Dev Neurosci 24 2002 389 395
65. J. Adams, D. Wu, J. Bassuk, J. Arias, H. Lozano, and P. Kurlansky Nitric oxide synthase isoform inhibition before whole body ischemia reperfusion in pigs: vital or protective? Resuscitation 74 2007 516 525
66. C.H. Nijboer, A. Kavelaars, F. van Bel, C.J. Heijnen, and F. Groenendaal Gender-dependent pathways of hypoxia-ischemia-induced cell death and neuroprotection in the immature P3 rat Dev Neurosci 29 2007 385 392
67. C.H. Nijboer, F. Groenendaal, A. Kavelaars, H.H. Hagberg, F. van Bel, and C.J. Heijnen Gender-specific neuroprotection by 2-iminobiotin after hypoxia-ischemia in the neonatal rat via a nitric oxide independent pathway J Cereb Blood Flow Metab 27 2007 282 292
68. N. Franks, R. Dickinson, S. de Sousa, A. Hall, and W. Lieb How does xenon produce anaesthesia? Nature 26 1998 324
69. M. Gruss, T.J. Bushell, D.P. Bright, W.R. Lieb, A. Mathie, and N.P. Franks Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane Mol Pharmacol 65 2004 443 452
70. C.P. Petzelt, S. Kodirov, G. Taschenberger, and W.J. Kox Participation of the Ca(2+)-calmodulin-activated Kinase II in the control of metaphase-anaphase transition in human cells Cell Biol Int 25 2001 403 409
71. D. Ma, P. Williamson, A. Januszewski, M.C. Nogaro, M. Hossain, and L.P. Ong Xenon mitigates isoflurane-induced neuronal apoptosis in the developing rodent brain Anaesthesiology 106 2007 746 753
72. D. Ma, T. Lim, J. Xu, H. Tang, Y. Wan, and H. Zhao Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation J Am Soc Nephrol 20 2009 713 720
73. J. Steffenson Inhalation analgesia-nitrous oxide-methoxflurane 1970 Williams & Wilkins Baltimore
74. G.A. Lane, M.L. Nahrwold, A.R. Tait, M. Taylor-Busch, P.J. Cohen, and A.R. Beaudoin Anesthetics as teratogens: nitrous oxide is fetotoxic, xenon is not Science 210 1980 899 901
75. G. Istaphanous, and A. Loepke General anesthetics and the developing brain Curr Opin Anaesthesiol 22 2009 368 373
76. T. Goto, H. Saito, M. Shinkai, Y. Nakata, F. Ichinose, and S. Morita Xenon provides faster emergence from anesthesia than does nitrous oxidesevoflurane or nitrous oxide-isoflurane Anaesthesiology 86 1997 1273 1278
77. D. Ma, M. Hossain, A. Chow, M. Arshad, R. Battson, and R. Sanders Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia Ann Neurol 58 2005 182 193
78. C. Hobbs, M. Thoresen, A. Tucker, K. Aquilina, E. Chakkarapani, and J. Dingley Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia Stroke 39 2008 1307 1313
79. M. Coburn, O. Kunitz, J.H. Baumert, K. Hecker, S. Haaf, and A. Zühlsdorff Randomized controlled trial of the haemodynamic and recovery effects of xenon or propofol anaesthesia Br J Anaesth 94 2005 198 202
80. B. Preckel, W. Schlack, T. Heibel, and H. Rütten Xenon produces minimal haemodynamic effects in rabbits with chronically compromised left ventricular function Br J Anaesth 88 2002 264 299
81. G. Greisen, and O. Pryds Intravenous 133Xe clearance in preterm neonates with respiratory distress. Internal validation of CBF infinity as a measure of global cerebral blood flow Scand J Clin Lab Invest 48 1988 673 678
82. D. Ma, M. Hossain, G.K. Pettet, Y. Luo, T. Lim, and S. Akimov Xenon preconditioning reduces brain damage from neonatal asphyxia in rats J Cereb Blood Flow Metab 26 2006 199 208
83. S. Wilhelm, D. Ma, M. Maze, and N. Franks Effects of xenon on in vitro and in vivo models of neuronal injury Anaesthesiology 96 2002 1485 1491
84. D. Ma, M. Hossain, N. Rajakumaraswamy, N.P. Franks, and M. Maze Combination of xenon and isoflurane produces a synergistic protective effect against oxygen-glucose deprivation injury in a neuronal-glial co-culture model Anaesthesiology 99 2003 748 751
85. J. Dingley, J. Tooley, H. Porter, and M. Thoresen Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia Stroke 37 2006 501 506
86. J.L. Martin, D. Ma, M. Hossain, J. Xu, R.D. Sanders, N.P. Franks, and M. Maze Asynchronous administration of xenon and hypothermia significantly reduces brain infarction in the neonatal rat Br J Anaesth 98 2007 236 240
87. Thoresen M, Hobbs CE, HC, Wood T, Chakkarapani E, Dingley J. Cooling combined with immediate or delayed xenon inhalation provides equivalent long-term neuroprotection after neonatal hypoxia-ischemia. J Cereb Blood Flow Metab 2009;29:707-14.
88. S. Faulkner, A. Bainbridge, T. Kato, M. Chandrasekaran, M. Hristova, and M. Liu Xenon augmented hypothermia reduces early lactate/NAA and cell death in Perinatal Asphyxia Ann Neurol 70 2011 133 150
89. E. Chakkarapani, J. Dingley, X. Liu, N. Hoque, K. Aquilina, and H. Porter Xenon enhances hypothermic neuroprotection in asphyxiated newborn pigs Ann Neurol 68 2010 330 341
90. Y. Luo, D. Ma, E. Leong, R. Sanders, B. Yu, and M. Hossain Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model Aneasthesiology 109 2008 782 789
91. M. Satomoto, Y. Satoh, K. Terui, H. Miyao, K. Takishima, and M. Ito Neonatal exposure to sevoflurane induces abnormal social behaviors and deficits in fear conditioning in mice Anesthesiology 110 2009 628 637
92. Y. Dong, G. Zhang, B. Zhang, R. Moir, W. Xia, and E. Marcantonio The common inhalational anesthetic sevoflurane induces apoptosis and increases beta-amyloid protein levels Arch Neurol 66 2009 620 631
93. Y. Lu, X. Wu, Y. Dong, Z. Xu, Y. Zhang, and Z. Xie Anesthetic sevoflurane causes neurotoxicity differently in neonatal naïve and Alzheimer disease transgenic mice Anesthesiology 112 2010 1404 1416
94. Thoresen M, Liu X, Tooley J, Chakkarapani E, Dingley J. First human use of 50% xenon inhalation during hypothermia for neonatal hypoxicischemic encephalopathy: the "Coolxenon" Feasibility Study. E-PAS20111660.7.
95. H.L. Torrance, M.J. Benders, J.B. Derks, C.M. Rademaker, A.F. Bos, and P. Van Den Berg Maternal allopurinol during fetal hypoxia lowers cord blood levels of the brain injury marker S-100B Pediatrics 124 2009 350 357
96. J.J. Kaandorp, M.J. Benders, C.M. Rademaker, H.L. Torrance, M.A. Oudijk, and T.R. de Haan Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study BMC Pregnancy Childbirth 10 2010 8
97. C. Palmer, J. Towfighi, R.L. Roberts, and D.F. Heitjan Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats Pediatr Res 33 1993 405 411
98. G.D. Williams, C. Palmer, D.F. Heitjan, and M.B. Smith Allopurinol preserves cerebral energy metabolism during perinatal hypoxia-ischemia: a 31P NMR study in unanesthetized immature rats Neurosci Lett 144 1992 103 106
99. W.D. Johnson, K.L. Kayser, J.B. Brenowitz, and S.F. Saedi A randomized controlled trial of allopurinol in coronary bypass surgery Am Heart J 121 1991 20 24
100. R.R. Clancy, S.A. McGaurn, J.E. Goin, D.G. Hirtz, W.I. Norwood, and J.W. Gaynor Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest Pediatrics 108 2001 61 70
101. C. van Kesteren, M.J. Benders, F. Groenendaal, F. van Bel, F.F. Ververs, and C.M. Rademaker Population pharmacokinetics of allopurinol in full-term neonates with perinatal asphyxia Ther Drug Monit 28 2006 339 344
102. T. Chaudhari, and W. McGuire Allopurinol for preventing mortality and morbidity in newborn infants with suspected hypoxic-ischaemic encephalopathy Cochrane Database Sys Rev 2 2008 CD006817
103. M.J. Benders, A.F. Bos, C.M. Rademaker, M. Rijken, H.L. Torrance, and F. Groenendaal Early postnatal allopurinol does not improve short term outcome after severe birth asphyxia Arch Dis Child 91 2006 F163 F165
104. T. Gunes, M.A. Ozturk, E. Koklu, K. Kose, and I. Gunes Effect of allopurinol supplementation on nitric oxide levels in asphyxiated newborns Pediatr Neurol 36 2007 17 24
105. F. Van Bel, M. Shadid, R.M. Moison, C.A. Dorrepaal, J. Fontijn, and L. Monteiro Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity Pediatrics 101 1998 185 193
106. Kaandorp J, van Bel F, Veen S, Derks J, Groenendaal F, Rijken M, et al. Long-term neuroprotective effects of allopurinol after moderate perinatal asphyxia. Follow-up of two randomised controlled trials. Arch Dis Child. In press 2011.
107. T. Jackson, A. Xu, J. Vita, and J.J. Keaney Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations Circ Res 83 1998 916 922
108. C. Rybakowski, B. Mohar, S. Wohlers, H. Leichtweiss, and H. Schröder The transport of vitamin C in the isolated human near-term placenta Eur J Obstet Gynecol Reprod Biol 62 1995 107 114
109. J. Huang, D. Agus, C. Winfree, S. Kiss, W. Mack, and R. McTaggart Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke Proc Natl Acad Sci U S A 98 2001 11720 11724
110. M. Covey, M. Murphy, C. Hobbs, R. Smith, and D. Oorschot Effect of the mitochondrial antioxidant, Mito Vitamin E, on hypoxic-ischemic striatal injury in neonatal rats: a dose-response and stereological study Exp Neurol 199 2006 513 519
111. M. Daneyemez, E. Kurt, A. Cosar, E. Yuce, and T. Ide Methylprednisolone and vitamin E therapy in perinatal hypoxic-ischemic brain damage in rats Neuroscience 92 1999 693 697
112. H. Aly, L. Abd-Rabboh, M. El-Dib, F. Nawwar, H. Hassan, and M. Aaref Ascorbic acid combined with ibuprofen in hypoxic ischemic encephalopathy: a randomized controlled trial J Perinatol 29 2009 438 443
113. O. Aruoma, B. Halliwell, B. Hoey, and J. Butler The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid Free Radic Biol Med 6 1989 593 597
114. B. Riggs, A. Bronstein, K. Kulig, P. Archer, and B. Rumack Acute acetaminophen overdose during pregnancy Obstet Gynaecol 74 1989 247 253
115. D. Xu, Y. Chen, H. Wang, L. Zhao, J. Wang, and W. Wei Effect of N-acetylcysteine on lipopolysaccharide-induced intra-uterine fetal death and intra-uterine growth retardation in mice Toxicol Sci 88 2005 525 533
116. M. Probyn, M. Cock, J. Duncan, M. Tolcos, N. Hale, and A. Shields The anti-inflammatory agent N-acetyl cysteine exacerbates endotoxin-induced hypoxemia and hypotension and induces polycythemia in the ovine fetus Neonatology 98 2010 118 127
117. K. Heard Acetylcysteine for acetaminophen poisoning N Engl J Med 359 2008 285 292
118. R. Horowitz, R. Dart, D. Jarvie, C. Bearer, and U. Gupta Placental transfer of N-acetylcysteine following human maternal acetaminophen toxicity J Toxicol Clin Toxicol 35 1997 447 451
119. M. Schaper, S. Gergely, J. Lykkesfeldt, J. Zbären, S. Leib, and M. Täuber Cerebral vasculature is the major target of oxidative protein alterations in bacterial meningitis J Neuropathol Exp Neurol 61 2002 605 613
120. M.K. Paintlia, A.S. Paintlia, E. Barbosa, I. Singh, and A.K. Singh N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain J Neurosci Res 78 2004 347 361
121. F. Lanté, J. Meunier, J. Guiramand, T. Maurice, M. Cavalier, and M. de Jesus Ferreira Neurodevelopmental damage after prenatal infection: role of oxidative stress in the fetal brain Free Radic Biol Med 42 2007 1231 1245
122. F. Lanté, J. Meunier, J. Guiramand, M. De Jesus Ferreira, G. Cambonie, and R. Aimar Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation Hippocampus 18 2008 602 609
123. F. Plaisant, A. Clippe, D. Vander Stricht, B. Knoops, and P. Gressens Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice Free Radic Biol Med 34 2003 862 872
124. J. Liu, T. Lee, C. Chen, D. Bagim, and P. Cheung N-acetylcysteine improves hemodynamics and reduces oxidative stress in the brains of newborn piglets with hypoxia-reoxygenation injury J Neurotrauma 27 2010 1865 1873
125. T. Lee, C. Tymafichuk, D. Bigam, and P. Cheung Effects of postresuscitation N-acetylcysteine on cerebral free radical production and perfusion during reoxygenation of hypoxic newborn piglets Pediatr Res 64 2008 256 261
126. M. Jatana, I. Singh, A. Singh, and D. Jenkins Combination of systemic hypothermia and N-acetylcysteine attenuates hypoxic-ischemic brain injury in neonatal rats Pediatr Res 59 2006 684 689
127. E. Morishita, S. Masuda, M. Nagao, Y. Yasuda, and R. Sasaki Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death Neuroscience 76 1997 105 116
128. S. Juul, D. Anderson, Y. Li, and R. Christensen Erythropoietin and erythropoietin receptor in the developing human central nervous system Pediatr Res 43 1998 40 49
129. M. Digicaylioglu, and S. Lipton Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades Nature 412 2001 641 647
130. N. Byts, A. Samoylenko, T. Fasshauer, M. Ivanisevic, L. Hennighausen, and H. Ehrenreich Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin Cell Death Differ 15 2008 783 792
131. L. Wang, M. Chopp, S. Gregg, R. Zhang, H. Teng, and A. Jiang Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF J Cereb Blood Flow Metab 28 2008 1361 1368
132. B. Viviani, S. Bartesaghi, E. Corsini, P. Villa, P. Ghezzi, and A. Garau Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor J Neurochem 93 2005 412 421
133. J. Widness, R. Schmidt, and S. Sawyer Erythropoietin transplacental passage-review of animal studies J Perinat Med 23 1995 61 70
134. F.F. Gonzalez, R. Abel, C.R. Almli, D. Mu, M. Wendland, and D.M. Ferriero Erythropoietin sustains cognitive function and brain volume after neonatal stroke Dev Neurosci 31 2009 403 411
135. B.A. Kellert, R.J. McPherson, and S.E. Juul A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats Pediatr Res 61 2007 451 455
136. J. Fauchre, C. Dame, R. Vonthein, B. Koller, S. Arri, and M. Wolf An approach to using recombinant erythropoietin for neuroprotection in very preterm infants Pediatrics 122 2008 375 382
137. Juul SE, McPherson, RJ, MR, Bauer LA, Ledbetter KJ, Gleason CA, Mayock DE. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics 2008;122:383-91.
138. L. Velly, L. Pellegrini, B. Guillet, N. Bruder, and P. Pisano Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword? Pharmacol Ther 128 2010 445 459
139. E. Spandou, Z. Papadopoulou, V. Soubasi, G. Karkavelas, C. Simeonidou, and A. Pazaiti Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats Brain Res 1045 2005 22 30
140. E. Demers, R. McPherson, and S. Juul Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia Pediatr Res 58 2005 297 301
141. H. Matsushita, M. Johnston, M. Lange, and M. Wilson Protective effect of erythropoietin in neonatal hypoxic ischemia in mice Neuroreport 14 2003 1757 1761
142. C. Zhu, W. Kang, F. Xu, X. Cheng, Z. Zhang, and L. Jia Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy Pediatrics 124 2009 e218 e226
143. H. Elmahdy, A.R. El-Mashad, H. El-Bahrawy, T. El-Gohary, A. El-Barbary, and H. Aly Human recombinant erythropoietin in asphyxia neonatorum: pilot trial Pediatrics 125 2010 e1135 e1142
144. N. Lakic, K. Surlan, A. Jerin, B. Meglic, N. Curk, and M. Bunc Importance of erythropoietin in brain protection after cardiac surgery: a pilot study Heart Surg Forum 13 2010 e185 e189
145. T. Mennini, M. De Paola, P. Bigini, C. Mastrotto, E. Fumagalli, and S. Barbera Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo Mol Med 12 2006 153 160
146. A.L. Sirén, T. Fasshauer, C. Bartels, and H. Ehrenreich Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system Neurotherapeutics 6 2009 108 127
147. B. Sturm, M. Helminger, H. Steinkellner, M.M. Heidari, H. Goldenberg, and B. Scheiber-Mojdehkar Carbamylated erythropoietin increases frataxin independent from the erythropoietin receptor Eur J Clin Invest 40 2010 561 565
148. A. Kirkeby, L. Torup, L. Bochsen, M. Kjalke, K. Abel, and K. Theilgaard-Monch High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO) Thromb Haemost 99 2008 720 728
149. L. Wang, Z.G. Zhang, S.R. Gregg, R.L. Zhang, Z. Jiao, and Y. LeTourneau The Sonic hedgehog pathway mediates carbamylated erythropoietin-enhanced proliferation and differentiation of adult neural progenitor cells J Biol Chem 282 2007 32462 32470
150. S. Pankratova, D. Kiryushko, K. Sonn, V. Soroka, L.B. Køhler, and M. Rathje Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor Brain 133 2010 2281 2294
151. L. Doyle, C. Crowther, P. Middleton, and S. Marret Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review Obstet Gynecol 113 2009 1327 1333
152. H. de Haan, A.J. Gunn, C.E. Williams, M.A. Heymann, and P.D. Gluckman Magnesium sulfate therapy during asphyxia in near-term fetal lambs does not compromise the fetus but does not reduce cerebral injury Am J Obstet Gynaecol 176 2009 18 27
153. J. Penrice, P. Amess, and S. Punwani Magnesium sulfate after transient hypoxia-ischemia fails to prevent delayed cerebral energy failure in the newborn piglet Pediatr Res 41 1997 443 447
154. M. Levene, M. Blennow, A. Whitelaw, E. Hankø, V. Fellman, and R. Hartley Acute effects of two different doses of magnesium sulphate in infants with birth asphyxia Arch Dis Child Fetal Neonatal Ed 73 1995 F174 F177
155. M. Fisher, and W. Schaebitz An overview of stroke therapy Arch Intern Med 160 2000 3196 3206
156. B. Martin, S. Ji, S. Maudsley, and M. Mattson "Control" laboratory rodents are metabolically morbid: why it matters Proc Natl Acad Sci 107 2010 6127 6133
157. Stroke therapy academic industry roundtable (Fisher M, chair) Recommendations for standards regarding preclinical neuroprotective and restorative drug development Stroke 30 1999 2752 2758
158. M. Fisher, G. Feuerstein, D. Howells, P. Hurn, T. Kent, and S. Savitz Update of the stroke therapy academic industry roundtable preclinical recommendations Stroke 40 2009 2244 2250